Supreme Court Ruling Bolsters Licensee Rights

Law360, New York (January 9, 2007, 12:00 AM EST) -- In an 8-1 decision that may lead more licensees to challenge patents, the Supreme Court on Tuesday sided with biotech company MedImmune Inc. in a royalty dispute with Genentech Inc. over an infant respiratory drug.

The ruling came amid wrangling between business and government over whether patents are too easily approved, preventing rather than inspiring inventions.

The biotech rivals have been battling over a Genentech patent covering Synagis, one of MedImmune’s blockbuster drugs, which brings in more than $1 billion in sales each year.

The High...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.